Personal CFO Solutions’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
20,294
-5,426
| -21% | -$374K | 0.26% | 76 |
|
|
2025
Q1 | $1.79M | Sell |
25,720
-1,411
| -5% | -$98K | 0.36% | 50 |
|
|
2024
Q4 | $2.33M | Sell |
27,131
-3,770
| -12% | -$324K | 0.46% | 39 |
|
|
2024
Q3 | $3.68M | Buy |
30,901
+114
| +0.4% | +$13.6K | 0.51% | 42 |
|
|
2024
Q2 | $4.39M | Buy |
30,787
+907
| +3% | +$129K | 0.68% | 27 |
|
|
2024
Q1 | $3.84M | Buy |
29,880
+106
| +0.4% | +$13.6K | 0.6% | 35 |
|
|
2023
Q4 | $3.08M | Sell |
29,774
-74
| -0.2% | -$7.66K | 0.53% | 38 |
|
|
2023
Q3 | $2.71M | Buy |
29,848
+4,390
| +17% | +$399K | 0.54% | 36 |
|
|
2023
Q2 | $2.06M | Sell |
25,458
-66
| -0.3% | -$5.34K | 0.42% | 56 |
|
|
2023
Q1 | $2.03M | Sell |
25,524
-414
| -2% | -$32.9K | 0.42% | 53 |
|
|
2022
Q4 | $1.76M | Sell |
25,938
-332
| -1% | -$22.5K | 0.37% | 53 |
|
|
2022
Q3 | $1.31M | Sell |
26,270
-978
| -4% | -$48.7K | 0.33% | 56 |
|
|
2022
Q2 | $1.52M | Buy |
27,248
+3,416
| +14% | +$190K | 0.36% | 51 |
|
|
2022
Q1 | $1.32M | Buy |
23,832
+15,752
| +195% | +$874K | 0.26% | 74 |
|
|
2021
Q4 | $452K | Buy |
8,080
+36
| +0.4% | +$2.01K | 0.08% | 218 |
|
|
2021
Q3 | $386K | Buy |
+8,044
| New | +$386K | 0.08% | 225 |
|
|
2021
Q1 | – | Sell |
-8,814
| Closed | -$308K | – | 435 |
|
|
2020
Q4 | $308K | Buy |
8,814
+396
| +5% | +$13.8K | 0.08% | 239 |
|
|
2020
Q3 | $0 | Buy |
8,418
+416
| +5% | – | ﹤0.01% | 271 |
|
|
2020
Q2 | $262K | Buy |
8,002
+530
| +7% | +$17.4K | 0.08% | 232 |
|
|
2020
Q1 | $225K | Sell |
7,472
-890
| -11% | -$26.8K | 0.08% | 218 |
|
|
2019
Q4 | $242K | Buy |
+8,362
| New | +$242K | 0.07% | 273 |
|